Marzieh Mohseni

Marzieh Mohseni

Auto-generated profile, based on publicly available information

Marzieh Mohseni

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MMMarzieh Mohseni
Marzieh Mohseni
MBMojgan Babanejad
Mojgan Babanejad
KBKevin T. Booth
Kevin T. Booth
PJPayman Jamali
Payman Jamali
KJKhadijeh Jalalvand
Khadijeh Jalalvand
HNHossein Najmabadi
Hossein Najmabadi

1 September 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MHMaryam Hosseinpour
Maryam Hosseinpour
FAFariba Ardalani
Fariba Ardalani
MMMarzieh Mohseni
Marzieh Mohseni
MBMaryam Beheshtian
Maryam Beheshtian
SASanaz Arzhangi
Sanaz Arzhangi
BBBehrooz Broumand
Behrooz Broumand
Background: Autosomal dominant polycystic kidney disease (ADPKD), one of the common inherited disorders in humans, is characterized by the development and enlargement of renal cysts, often leading to end-stage renal disease (ESRD). In this study, Iranian ADPKD families were subjected to high-throughput DNA sequencing to find potential causative variants facilitating the way toward risk assessment and targeted therapy. Methods: Our protocol was based on the targeted next generation sequencing (NGS) panel previously developed in our center comprising 12 genes involved in PKD. This panel has been applied to investigate the genetic causes of 32 patients with a clinical suspicion of ADPKD. Results: We identified a total of 31 variants for 32 individuals, two of which were each detected in two individuals. Twenty-seven out of 31 detected variants were interpreted as pathogenic/likely pathogenic and the remaining 4 of uncertain significance with a molecular diagnostic success rate of 87.5%. Among these variants, 25 PKD1/2 pathogenic/likely pathogenic variants were detected in 32 index patients (78.1%), and variants of uncertain significance in four individuals (12.5% in PKD1/2). The majority of variants was identified in PKD1 (74.2%). Autosomal recessive PKD was identified in one patient, indicating the similarities between recessive and dominant PKD. In concordance with earlier studies, this biallelic PKD1 variant, p.Arg3277Cys, leads to rapidly progressive and severe disease with very early-onset ADPKD. Conclusion: Our findings suggest that targeted gene panel sequencing is expected to be the method of choice to improve diagnostic and prognostic accuracy in PKD patients with heterogeneity in genetic background.

19 March 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
FJFereshteh Jamshidi
Fereshteh Jamshidi
ESEbrahim Shokouhian
Ebrahim Shokouhian
MMMarzieh Mohseni
Marzieh Mohseni
KKKimia Kahrizi
Kimia Kahrizi
HNHossein Najmabadi
Hossein Najmabadi
MBMojgan Babanejad
Mojgan Babanejad
Background: To date, over 400 syndromes with hearing impairment have been identified which altogether constitute almost 30% of hereditary hearing loss (HL) cases around the globe. Manifested as complete or partial labyrinthine aplasia (severe malformations of the inner ear structure), type I microtia (smaller outer ear with shortened auricles), and microdontia (small and widely spaced teeth), labyrinthine aplasia, microtia, and microdontia (LAMM) syndrome (OMIM 610706) is an extremely rare autosomal recessive condition caused by bi‐allelic mutations in the FGF3 gene.Methods: Using the whole‐exome sequencing (WES) data of the proband, we analyzed a consanguineous Iranian family with three affected members presenting with congenital bilateral HL, type I microtia, and microdontia.Results: We discovered the homozygous deletion c.45delC in the first exon of the FGF3 gene, overlapping a 38.72 Mb homozygosity region in chromosome 11. Further investigations using Sanger sequencing revealed that this variant co‐segregated with the phenotype observed in the family.Conclusion: Here, we report the first identified case of LAMM syndrome in Iran, and by identifying a frameshift variant in the first exon of the FGF3 gene, our result will help better clarify the phenotype–genotype relation of LAMM syndrome.

4 February 2024 in Clinical Genetics
Verified
Journal Article
Closed access
SMSepideh Mehvari
Sepideh Mehvari
NFNahid Karimian Fathi
Nahid Karimian Fathi
SSSara Saki
Sara Saki
MAMaryam Asadnezhad
Maryam Asadnezhad
SASanaz Arzhangi
Sanaz Arzhangi
KKKimia Kahrizi
Kimia Kahrizi

8 August 2025 in BMJ Case Reports
Verified
Journal Article
Open access
YZYuzhou Zhang
Yuzhou Zhang
MMMahdi Malekpour
Mahdi Malekpour
NANavid Al-Madani
Navid Al-Madani
KKKimia Kahrizi
Kimia Kahrizi
MZMarvam Zanganeh
Marvam Zanganeh
RSRichard J. H. Smith
Richard J. H. Smith
Syndromic hearing loss that results from contiguous gene deletions is uncommon.Three families with a novel syndrome characterised by deafness and infertility are described. Linkage was established by completing a genome-wide scan and candidate genes in the linked region were screened by direct sequencing. The deleted region is about 100 kb long and involves four genes (KIAA0377, CKMT1B, STRC and CATSPER2), each of which has a telomeric duplicate. This genomic architecture underlies the mechanism by which these deletions occur. CATSPER2 and STRC are expressed in the sperm and inner ear, respectively, consistent with the phenotype in persons homozygous for this deletion. A deletion of this region has been reported in one other family segregating male infertility and sensorineural deafness. We have identified three families segregating an autosomal recessive contiguous gene deletion syndrome characterised by deafness and sperm dysmotility. This new syndrome is caused by the deletion of contiguous genes at 15q15.3.

1 March 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMarzieh Mohseni
Marzieh Mohseni
YMYusuf Mohammadi
Yusuf Mohammadi
FAFarzane Zare Ashrafi
Farzane Zare Ashrafi
FGFatemeh Ghodratpour
Fatemeh Ghodratpour
KJKhadijeh Jalalvand
Khadijeh Jalalvand
HNHossein Najmabadi
Hossein Najmabadi
Genetic analysis of non-syndromic hearing loss (NSHL) has been challenged due to marked clinical and genetic heterogeneity. Today, advanced next-generation sequencing (NGS) technologies, such as exome sequencing (ES), have drastically increased the efficacy of gene identification in heterogeneous Mendelian disorders. Here, we present the utility of ES and re-evaluate the phenotypic data for identifying candidate causal variants for previously unexplained progressive moderate to severe NSHL in an extended Iranian family. Using this method, we identified a known heterozygous nonsense variant in exon 26 of the DIAPH1 gene (MIM: 602121), which led to "Deafness, autosomal dominant 1, with or without thrombocytopenia; DFNA1" (MIM: 124900) in this large family in the absence of GJB2 disease-causing variants and also OtoSCOPE-negative results. To the best of our knowledge, this nonsense variant (NM_001079812.3):c.3610C>T (p.Arg1204Ter) is the first report of the DIAPH1 gene variant for autosomal dominant non-syndromic hearing loss (ADNSHL) in Iran.